Y21 Pill: Eszopiclone 1 mg Identification, Uses and Risks

The pill marked LU on one side and Y21 on the other is eszopiclone 1 mg. DailyMed describes the legitimate tablet as light blue, round, biconvex, and film-coated. Eszopiclone is a prescription sedative-hypnotic used to treat insomnia and is federally classified as a Schedule IV controlled substance.

LU Y21 is sometimes mistaken for Ambien or zolpidem because both are prescription “Z-drugs” used for insomnia. They are not the same medication. Y21 contains eszopiclone, the active ingredient in Lunesta, not zolpidem.

Eszopiclone carries an FDA boxed warning for complex sleep behaviors such as sleepwalking, sleep-driving, preparing food, making calls, or engaging in other activities while not fully awake. Serious injuries and deaths have occurred. The medication can also cause next-day impairment even when a person feels awake.

LU Y21 Pill Identification

What Is the Y21 Pill?

Y21 is an eszopiclone tablet used for the treatment of insomnia in adults. DailyMed states that eszopiclone has been shown to decrease sleep latency and improve sleep maintenance.

The characters LU and Y21 are product-identification markings. The strength is 1 mg. Related tablets in the same product line use different colors and imprints for higher strengths: Y22 identifies a 2 mg tablet and Y23 identifies a 3 mg tablet in the reviewed DailyMed labeling.

Is Y21 Lunesta?

Y21 contains eszopiclone, the active ingredient sold under the brand name Lunesta. The Y21 tablet itself is a generic eszopiclone product rather than a brand-name Lunesta tablet.

This is similar to how a generic alprazolam tablet contains the same active ingredient as Xanax but can have a different imprint and appearance.

Is Y21 Ambien?

No. Ambien contains zolpidem. Y21 contains eszopiclone. Both are nonbenzodiazepine sedative-hypnotics often grouped as Z-drugs, but they are different medications.

Both drug types have important impairment and complex-sleep-behavior warnings. Pill identification should therefore rely on the exact imprint and official labeling instead of assuming every prescription sleep tablet is Ambien.

What Is Eszopiclone Used For?

Eszopiclone is FDA-approved for insomnia. Its clinical trials included both sleep-onset and sleep-maintenance outcomes. It is intended as a prescription treatment after a healthcare professional evaluates the sleep problem and other medical or psychiatric factors that may be contributing.

Persistent insomnia can be a symptom of another medical, sleep, or psychiatric condition. Current labeling recommends reevaluation when insomnia fails to improve after a short treatment interval because an underlying disorder may need to be addressed.

What Is the FDA Boxed Warning for Eszopiclone?

The boxed warning concerns complex sleep behaviors. These are activities carried out while a person is not fully awake and may not remember the next morning.

Reported behaviors include:

• Sleepwalking
• Sleep-driving
• Preparing or eating food
• Making phone calls
• Other activities performed while not fully awake

FDA and DailyMed state that serious injuries and deaths have occurred. Eszopiclone is contraindicated in people who have previously experienced a complex sleep behavior after taking the drug.

Can Y21 Cause Next-Day Impairment?

Yes. Eszopiclone can impair alertness, coordination, thinking, and driving ability the next day. Current labeling warns that impairment can be present even when the person feels fully awake.

The risk can increase when a person does not have enough time for a full night’s sleep, uses higher doses, combines eszopiclone with other central nervous system depressants, or uses alcohol.

Common Side Effects of Eszopiclone

Clinical-trial labeling reports several adverse effects, including:

• Unpleasant or altered taste
• Headache
• Dry mouth
• Dizziness
• Somnolence
• Nausea or indigestion
• Abnormal dreams in some patients

An unpleasant taste is particularly characteristic of eszopiclone and showed a dose-related pattern in clinical trials.

Why Is Eszopiclone Schedule IV?

DailyMed states that eszopiclone is a Schedule IV controlled substance. The label distinguishes abuse and addiction from physical dependence and tolerance but recognizes that the medication can be misused and can lead to dependence.

Controlled status is one reason the medication should be kept secure and should not be shared with another person.

Is Eszopiclone a Benzodiazepine?

No. Eszopiclone is chemically different from benzodiazepines and is classified as a nonbenzodiazepine sedative-hypnotic, commonly grouped with the “Z-drugs.” The distinction is important for identification, but it does not mean eszopiclone lacks benzodiazepine-like safety concerns. DailyMed notes that eszopiclone shares some pharmacologic properties with benzodiazepines and is also a Schedule IV controlled substance.

Both types of drugs can impair alertness and coordination and can become more dangerous when combined with alcohol, opioids, or other sedating medications. A reader should therefore distinguish the drug class correctly without interpreting “nonbenzodiazepine” as “non-sedating” or “non-habit-forming.”

Y21 and Alcohol

Eszopiclone labeling instructs patients not to take it if they drank alcohol that evening or before bed. Alcohol can increase central nervous system depression, drowsiness, impaired judgment, and the risk of dangerous sleep-related behaviors.

A person should also tell the prescriber about other sedating medications, including opioids, benzodiazepines, antihistamines, and other sleep medicines.

Y21 and Other Sedatives

Combining multiple central nervous system depressants can increase impairment and excessive sedation. The interaction is especially concerning when the other substance can also suppress breathing or awareness.

A person should not “stack” prescription sleep medicines or add a benzodiazepine or opioid simply because sleep has not occurred as quickly as expected.

Can Eszopiclone Cause Dependence?

Yes. Eszopiclone is controlled partly because of abuse and dependence potential. Continued use can lead to adaptation, and some people may experience withdrawal-like symptoms after discontinuation.

Dependence is not identical to addiction. Addiction involves problematic use and impaired control, while physical dependence describes physiologic adaptation. A clinician can help distinguish rebound insomnia, withdrawal symptoms, and recurrence of the original sleep disorder.

Can Complex Sleep Behaviors Happen at a Recommended Dose?

Yes. DailyMed states that postmarketing reports of complex sleep behaviors have occurred with eszopiclone alone at recommended dosages, with or without alcohol or other central nervous system depressants. The events can occur after the first use or after a later dose, and people often do not remember what happened.

This is why the boxed warning is not limited to people who misuse the medication. A person who experiences sleep-driving, sleepwalking, preparing food, making calls, or another complex activity while not fully awake should stop the medication and contact the prescriber as directed by the label.

Abnormal Thinking, Behavior Changes and Depression

Eszopiclone labeling also describes abnormal thinking and behavioral changes, including agitation, unusual disinhibition, hallucinations, and behavior that seems out of character. Sedative-hypnotics require additional caution in people with depression because worsening depression and suicidal thoughts or actions have been reported.

New hallucinations, severe confusion, suicidal thoughts, or a marked behavioral change deserve prompt clinical attention rather than being treated as a routine sleep-medication side effect.

Can Stopping Eszopiclone Cause Withdrawal or Rebound Insomnia?

Rapid dose reduction or abrupt discontinuation of sedative-hypnotics can produce withdrawal-like symptoms. In eszopiclone trials, symptoms reported after discontinuation included anxiety, abnormal dreams, nausea, and upset stomach in a small percentage of participants.

Sleep can also temporarily worsen after a hypnotic is stopped, a phenomenon called rebound insomnia. A person using eszopiclone regularly should discuss discontinuation with the prescriber instead of escalating, stopping, or substituting another sedative without guidance.

Why a Full Night of Sleep Matters

Current labeling warns that next-day psychomotor impairment is more likely when eszopiclone is taken without enough time remaining for a full night’s sleep. The concern is not only feeling tired. Coordination, reaction time, and judgment can be impaired even when a person believes they are fully awake.

This risk becomes more important when alcohol, opioids, benzodiazepines, other hypnotics, or medications that raise eszopiclone blood levels are also involved.

Severe Allergic Reactions

Rare severe allergic reactions, including swelling involving the tongue, throat, or airway, have been reported with eszopiclone. Difficulty breathing, throat closing, or significant swelling after taking the medication requires emergency medical care.

Can You Overdose on Y21?

Taking more eszopiclone than prescribed can cause excessive central nervous system depression and requires medical assessment, especially when other depressants are involved.

An unresponsive person, someone with abnormal breathing, severe confusion, loss of consciousness, or suspected mixed-drug ingestion needs emergency help. Because counterfeit pills can contain unexpected substances, emergency responders should be told if the source of the tablet was uncertain.

Can Y21 Be Counterfeit?

Yes. As with any prescription drug, an illicitly manufactured tablet can imitate a legitimate imprint. FDA warns that counterfeit medicines may contain incorrect ingredients or amounts and can include harmful substances.

A legitimate prescription dispensed by a licensed pharmacy has a traceable source. A loose pill sold as “Lunesta” online or through social media does not have that same assurance.

Y21 vs. Y22 vs. Y23

Those strengths are included for identification, not as instructions for choosing or changing a dose. Eszopiclone should be taken only according to the prescription.

What Should You Do if a Y21 Pill Looks Different?

If your pharmacy-dispensed eszopiclone looks different from a prior refill, check the prescription bottle and ask the pharmacist to confirm the manufacturer and strength. Generic appearance can change when a pharmacy uses a different supplier.

If the tablet did not come from your pharmacy, do not rely on an image search to decide whether it is safe to take.

When to Seek Help for Eszopiclone Misuse

Warning signs include taking more than prescribed, combining eszopiclone with alcohol or other sedatives, using another person’s medication, repeatedly seeking early refills, or feeling unable to sleep without escalating use.

Assessment can determine whether the issue is insomnia management, medication dependence, polysubstance use, or a substance use disorder. Rehabs.Today can help compare residential treatment programs and other treatment resources when substance misuse is part of the problem.

Frequently Asked Questions About Y21

What pill has LU and Y21 on it?

DailyMed identifies LU/Y21 as eszopiclone 1 mg, a light blue round film-coated tablet.

Is Y21 Lunesta?

Y21 is generic eszopiclone, the same active medication used in Lunesta.

Is Y21 Ambien?

No. Ambien contains zolpidem. Y21 contains eszopiclone.

Is Y21 a benzodiazepine?

No. Eszopiclone is a nonbenzodiazepine sedative-hypnotic, often called a Z-drug, although it shares some pharmacologic effects with benzodiazepines.

Is Y21 controlled?

Yes. Eszopiclone is a Schedule IV controlled substance.

What is the most serious warning for eszopiclone?

Eszopiclone has an FDA boxed warning for complex sleep behaviors that can cause serious injury or death, including sleep-driving and other activities while not fully awake.

Can Y21 make you impaired the next morning?

Yes. Eszopiclone can cause next-day impairment even when a person feels fully awake.

Sources

• DailyMed — Eszopiclone / LU Y21: Y21 identification, insomnia indication, controlled-substance status, adverse effects and boxed warning.
• FDA — Z-Drug Boxed Warning: FDA warning on complex sleep behaviors with eszopiclone, zaleplon and zolpidem.
• FDA — Taking Z-Drugs for Insomnia? Know the Risks: Consumer safety information on Z-drugs and complex sleep behavior.
• FDA — Counterfeit Medicine: Current counterfeit-medicine guidance.